EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integration of osimertinib-targeted EGFR gene-associated differential gene expression in constructing a prognostic model for lung adenocarcinoma

Haiwen Li, Li Yang, Quan Yang, Zhu Liang, Wenmei Su, Lili Yu

Functional & Integrative Genomics · 2024-12 · 24 (6)

DOI: 10.1007/s10142-024-01499-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Functional & Integrative Genomics, online erschienen am 11.12.2024. Verfasst von Haiwen Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, 999078, P.R. China. Hauptthemen laut MEDLINE: Acrylamides, Adenocarcinoma of Lung, ErbB Receptors, Aniline Compounds. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung adenocarcinoma (LUAD) is one of the deadliest cancers. Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-targeted therapy is an important approach for treating LUAD. However, the development of acquired resistance poses a serious clinical challenge. Our objective was to explore the differentially expressed genes (DEGs) associated with EGFR and detect biomarkers for diagnosing and treating osimertinib resistance in LUAD patients. LUAD datasets were downloaded from public databases. Differential expression analysis was performed to screen DEGs, and prognostic modules were constructed by Cox regression. Enrichment analysis, gene regulatory network analysis and immune microenvironment analysis were employed to explore the underlying mechanisms in LUAD. Finally, the expression of prognosis module genes (PMGs) was validated in 8 LUAD tissue specimens and 5 cell lines by qRT-PCR. In total, 13 differential module genes (BIRC3, CCT6A, CPLX2, GLCCI1, GSTA1, HLA-DQB2, ID1, KCTD12, MUC15, NOTUM, NT5E, TCIM, and TM4SF4) were screened for the construction of a prognostic module. Notably, CCT6A and KCTD12 demonstrated excellent accuracy in the diagnosis of LUAD. Immune dysregulation and BIRC3, HLA-DQB2, KCTD12, and NT5E expression were significantly associated with invasive immune cells in LUAD patients. The expression level of CCT6A was highest in PC9-OR and H1975-OR cells, while the expression level of KCTD12 was highest in paracancerous tissue and HBE cells. The constructed prognostic model showed promise in predicting the survival of LUAD patients. Notably, KCTD12 and CCT6A might be candidate biomarkers for improving diagnostic performance and guiding individualized therapy for EGFR-TKI-resistant LUAD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcrylamidesAdenocarcinoma of LungErbB ReceptorsAniline CompoundsLung NeoplasmsGene Expression Regulation, NeoplasticHumansPrognosisBiomarkers, TumorDrug Resistance, NeoplasmCell Line, TumorGene Regulatory NetworksAntineoplastic AgentsProtein Kinase InhibitorsTumor MicroenvironmentIndolesPyrimidines

Stichwörter der Autor:innen

CCT6AKCTD12EGFR-TKI resistanceLung adenocarcinomaPrognostic model

Substanzen

osimertinibAcrylamidesErbB ReceptorsAniline CompoundsEGFR protein, humanBiomarkers, TumorAntineoplastic AgentsProtein Kinase InhibitorsIndolesPyrimidines

Autor:innen und Institutionen

  • Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, 999078, P.R. China.
  • Department of Head and Neck Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524000, P.R. China.
  • Department of Digestive Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524000, P.R. China.
  • Department of Pulmonary Oncology, Affiliated Hospital of Guangdong Medical University, 57 South Renmin Road, Zhanjiang, Guangdong Province, 524000, P.R. China.
  • Department of Cardiovascular and Thoracic Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524000, P.R. China.
  • Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, 999078, P.R. China. suwenmei123@hotmail.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, H., Yang, L., Yang, Q., Liang, Z., Su, W., & Yu, L. (2024). Integration of osimertinib-targeted EGFR gene-associated differential gene expression in constructing a prognostic model for lung adenocarcinoma. Functional & Integrative Genomics, 24(6). https://doi.org/10.1007/s10142-024-01499-5

Vancouver

Li H, Yang L, Yang Q, Liang Z, Su W, Yu L. Integration of osimertinib-targeted EGFR gene-associated differential gene expression in constructing a prognostic model for lung adenocarcinoma. Functional & Integrative Genomics. 2024;24(6). doi:10.1007/s10142-024-01499-5

BibTeX
@article{Li2024,
  author = {Li, Haiwen and Yang, Li and Yang, Quan and Liang, Zhu and Su, Wenmei and Yu, Lili},
  title = {Integration of osimertinib-targeted EGFR gene-associated differential gene expression in constructing a prognostic model for lung adenocarcinoma},
  journal = {Functional & Integrative Genomics},
  year = {2024},
  volume = {24},
  number = {6},
  doi = {10.1007/s10142-024-01499-5}
}
Kostenlos starten →